Healthcare

Key HighlightsThe 15-centInterim Dividendis Neuren's maiden payment and totals about A$19.0 million, representing roughly 90 per cent of a A$21.1 million available pool the board set aside from after-taxRoyaltyincome.The dividend is funded by growing royalties from DAYBUE (trofinetide), the Rett syndrome treatment commercialised in …

Mayne Pharma Group Limited (ASX:MYX), trading on the Australian Securities Exchange under the code MYX, has announced the completion of an exclusive, long-term licensing agreement with Italfarmaco S.A for the Australian rights to Blissel, an ultra-low-dose estriol vaginal gel developed for the treatment of …

Anatara Lifesciences Limited (ASX:ANR), listed on the Australian Securities Exchange under the code ANR, has lodged a notice disclosing a change in the interests held by one of its directors, John Michailidis. The filing, submitted in the standard form used across the exchange for …

nib Holdings operates in private health insurance and adjacent services. ItsBusinessmodel determines how cash is generated and which earnings measures are most relevant toShareholderpayments. Revenue, operating costs, financing expenses, tax andCapital Expenditurecan each affect the amount available for distribution. The company's reporting measures therefore …

EBOS Group operates in healthcare and animal-care product distribution. ItsBusinessmodel determines how cash is generated and which earnings measures are most relevant toShareholderpayments. Revenue, operating costs, financing expenses, tax andCapital Expenditurecan each affect the amount available for distribution. The company's reporting measures therefore need …

Little Green Pharma (ASX:LGP) has undergone a major transformation following its merger with Cannatrek, shifting from a smaller medicinal cannabis producer into a larger vertically integrated cannabis business.

Amplia Therapeutics (ASX:ATX) is progressing a clinical-stage oncology pipeline centred on narmafotinib, a focal adhesion kinase (FAK) inhibitor being evaluated across several cancer indications.